The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
TheHealthSite.com on MSN3h
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All About This DrugThe US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
ScienceAlert on MSN18h
FDA-Approved Nasal Spray For Depression Is First Of Its KindA ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.
Hosted on MSN20h
FDA approves Spravato, nasal spray derived from KetamineThe FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.
People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...
As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback